Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-09-26

Clinical Trial Update: Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin Alone [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating insulin plus glucagon versus insulin alone in Type 1 diabetes with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLUCAGON (GLUCAGON)
  • Insulin (insulin)

Snippet

Sponsor: Legacy Health System | Conditions: Type 1 Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2011-09-26